Phenylketonuria Trial, Recruiting (NCT07484945)

Phenylketonuria Trial, Recruiting NCT07484945 Sponsor: University Hospital, Tours Condition: Phenylketonuria

Printed from Voxsanity (voxsanity.com.au) — NCT07484945 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Phenylketonuria

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You must be 18 years old or older and have been diagnosed with PKU (Phenylketonuria)
Your PKU must have been found through a newborn screening test (the routine blood test done shortly after birth)
You must have taken part in and completed the final visit of a previous study called the ECOPHEN study
You must be covered by a health insurance plan
You must be willing and able to sign and date a consent form agreeing to provide a saliva sample for DNA testing

Who may not be able to join:

You may not be eligible if your PKU was not discovered through the standard newborn screening program (for example, if it was diagnosed another way or later in life)
You may not be eligible if you are unwilling or unable to sign and date a consent form
You may not be eligible if you are unable to provide a saliva sample

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yannick MOUPATAM-NGAMBY-ADRIAASEN, Sir, University, Tours

Phone: 2.47.47.37.15

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07484945

Sponsor: University Hospital, Tours

Phase: Not Applicable

Status: Recruiting

Condition: Phenylketonuria

Trial contact: 2.47.47.37.15

More information: https://clinicaltrials.gov/study/NCT07484945

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You must be 18 years old or older and have been diagnosed with PKU (Phenylketonuria)
Your PKU must have been found through a newborn screening test (the routine blood test done shortly after birth)
You must have taken part in and completed the final visit of a previous study called the ECOPHEN study
You must be covered by a health insurance plan
You must be willing and able to sign and date a consent form agreeing to provide a saliva sample for DNA testing

Who may not be able to join:

You may not be eligible if your PKU was not discovered through the standard newborn screening program (for example, if it was diagnosed another way or later in life)
You may not be eligible if you are unwilling or unable to sign and date a consent form
You may not be eligible if you are unable to provide a saliva sample

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Tours

Registry

ClinicalTrials.gov

Start date

23 March 2026

Est. completion

1 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Identification of metabolite clusters; Identification of genetic variants DNAJC12, HULC, SLC7A5, and SHANK and other ones

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov